Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit.

Here we describe an outbreak caused by a pandrug-resistant Providencia stuartii strain involving 15 critically ill patients in a Greek intensive care unit (ICU) during September-November 2011. All isolates harboured the blaVIM-1 gene and a class 1 integron structure of 1913 bp as well as blaSHV-5 and blaTEM-1. Pulsed-field gel electrophoresis (PFGE) demonstrated that isolates from all 15 patients belonged to a single P. stuartii clonal type. As all of the infected patients were hospitalised during overlapping time periods, horizontal intra-ICU transmission was considered as the main route for the dissemination of the outbreak strain. The outbreak ended following reinforcement of infection control measures, including implementation of additional barrier precautions for infected patients.

[1]  P. Nordmann,et al.  How To Detect NDM-1 Producers , 2010, Journal of Clinical Microbiology.

[2]  E. Mahenthiralingam,et al.  Molecular Epidemiology of Proteus mirabilis Infections of the Catheterized Urinary Tract , 2003, Journal of Clinical Microbiology.

[3]  G. Fadda,et al.  ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. , 2004, The Journal of antimicrobial chemotherapy.

[4]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  G. Arlet,et al.  Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. , 2010, The Journal of antimicrobial chemotherapy.

[6]  Chantal D. Larose,et al.  PCR mapping of integrons reveals several novel combinations of resistance genes , 1995, Antimicrobial agents and chemotherapy.

[7]  C. Roussos,et al.  Risk factors for and influence of bloodstream infections on mortality: a 1-year prospective study in a Greek intensive-care unit , 2008, Epidemiology and Infection.

[8]  V. Miriagou,et al.  Providencia stuartii with VIM-1 metallo-β-lactamase , 2007 .

[9]  S. Pournaras,et al.  Evaluation of Boronic Acid Disk Tests for Differentiating KPC-Possessing Klebsiella pneumoniae Isolates in the Clinical Laboratory , 2008, Journal of Clinical Microbiology.

[10]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .

[11]  U. Pennsylvania,et al.  Clinical and Laboratory Standards Institute , 2019, Springer Reference Medizin.

[12]  M. Souli,et al.  Nosocomial dissemination of Providencia stuartii isolates producing extended-spectrum β-lactamases VEB-1 and SHV-5, metallo-β-lactamase VIM-1, and RNA methylase RmtB. , 2013, Journal of global antimicrobial resistance.

[13]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[14]  A. Gales,et al.  Outbreak of Carbapenem-Resistant Providencia stuartii in an Intensive Care Unit , 2012, Infection Control & Hospital Epidemiology.

[15]  M. Castanheira,et al.  Isolation of Genetically Unrelated bla NDM-1-Positive Providencia rettgeri Strains in Israel , 2013, Journal of Clinical Microbiology.

[16]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[17]  A. Chaari,et al.  Nosocomial dissemination of Providencia stuartii isolates carrying bla OXA-48, bla PER-1, bla CMY-4 and qnrA6 in a Tunisian hospital. , 2013, The Journal of antimicrobial chemotherapy.